Hasta La Gadget!

“I’m not praying any of these people get hurt or harmed, but they need to see firsthand how bad the streets really are,” the Blue Lives Matter founder said.

The last year has been a boon for social media scammers, according to a new report from the FTC. The agency says more than 95,000 people lost $770 million to scammers who found them via social media platforms in 2021. That’s more than double the $258 million they say scammers made off with in 2020.

The report doesn’t speculate on why there was such a big increase in 2021, but it notes that reports of scams have “soared” over the last five years. It also states that there was a “massive surge” in scams related to “bogus cryptocurrency investments” and that investment scams accounted for nearly $285 million — more than third — of the $770 million lost last year.

Romance scams have also “climbed to record highs in recent years,” according to the report. “These scams often start with a seemingly innocent friend request from a stranger, followed by sweet talk, and then, inevitably, a request for money,” the FTC says. Also prevalent are scams related to online shopping, most of which involve “undelivered goods” that were purchased as the result of an ad on social media.

Of note, Facebook and Instagram are the only two platforms named in the report. “More than a third of people who said they lost money to an online romance scam in 2021 said it began on Facebook or Instagram,” the report states. Likewise, the FTC says that Facebook and Instagram were the most commonly cited platform for reports of undelivered good, with the two apps cited in 9 out of 10 reports where a service was identified.

“We put significant resources towards tackling this kind of fraud and abuse,” a spokesperson for Meta said in a statement. “We also go beyond suspending and deleting accounts, Pages, and ads. We take legal action against those responsible when we can and always encourage people to report this behavior when they see it.”

Interestingly one of the FTC’s recommendations is that users try to opt out of targeted advertising when possible as scammers can “easily use the tools available to advertisers on social media platforms to systematically target people with bogus ads based on personal details such as their age, interests, or past purchases.” The agency also recommends users lock down their privacy settings and to be wary of any messages asking for money, especially in the form of cryptocurrency or gift cards.

Research published earlier this week shows that a nasty Android banking malware has evolved, bringing with it a number of alarming new features—including the ability to factory reset your device after stealing your money.

Read more…

Brian K. Vaughan and Fiona Staples never intended for Saga to be gone this long. When they announced that the beloved Image Comics series would go on hiatus in 2018, it was expected to last about a year. Until… it didn’t. And now Saga is back to pick up the pieces it left behind, adding a fascinating twist to one of…

Read more…

Moderna has begun early-stage clinical trials of an HIV mRNA vaccine, the company announced this week. On Thursday, it administered the first doses of a shot it co-developed with the International AIDS Vaccine Initiative to volunteers at the George Washington University School of Medicine and Health Sciences.

Like the company’s COVID-19 vaccine, the new treatment uses messenger RNA to “trick” the human body into producing proteins that will trigger an immune response. Moderna hopes the shot will induce a specific class of white blood cells known as B-cells, which can then turn into broadly neutralizing antibodies. Those proteins are “widely considered to be the goal of HIV vaccination, and this is the first step in that process,” according to the company.

As part of the trial, Moderna plans to test both a primary vaccine and a booster shot. The Phase 1 trial will involve 56 healthy, HIV-negative adult participants. The company will give 48 of those individuals the mRNA vaccine. Thirty-two of that group will also receive the booster shot. To the final eight involved in the first trial, the company will only administer the booster shot. Moderna says it will then monitor the entire group for six months to gauge the safety of the vaccine. It also plans to examine the immune response the vaccine triggers at the molecular level to determine if it’s effective.

Messenger RNA technology could lead to treatments for a host of deadly diseases, including malaria, but a breakthrough against HIV would be particularly noteworthy. According to statistics from the US government, approximately 1.2 million Americans have the virus, which can lead to the deadly AIDS disease. While outcomes for HIV patients have improved significantly since the ‘90s thanks to the development of new treatments and medication, no HIV vaccine has successfully passed early clinical trials.